Holen Sie sich die Stockscreener-App
72.07
3.88%
2.69
Handel nachbörslich:
74.20
2.13
+2.96%
Schlusskurs vom Vortag:
$69.38
Offen:
$69.16
24-Stunden-Volumen:
674.47K
Relative Volume:
1.20
Marktkapitalisierung:
$2.04B
Einnahmen:
$267.23M
Nettoeinkommen (Verlust:
$-83.50M
KGV:
-2.0267
EPS:
-35.5597
Netto-Cashflow:
$-59.99M
1W Leistung:
-2.25%
1M Leistung:
+23.85%
6M Leistung:
+247.33%
1J Leistung:
+5,048%
1-Tages-Spanne:
$69.00
$75.49
1-Wochen-Bereich:
$66.00
$75.49
52-Wochen-Spanne:
$1.32
$89.11
Genedx Holdings Corp Stock (WGS) Company Profile
Firmenname
Genedx Holdings Corp
Sektor
Branche
Telefon
617 780 8742
Adresse
333 LUDLOW STREET, STAMFORD
Vergleichen Sie WGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| WGS | 72.07 | 2.04B | 267.23M | -83.50M | -59.99M | -35.56 |
| VEEV | 214.54 | 34.58B | 2.57B | 615.26M | 996.76M | 3.32 |
| SOLV | 69.63 | 11.99B | 8.25B | 404.00M | 1.52B | 0.00 |
| DOCS | 48.00 | 9.14B | 493.63M | 160.55M | 162.20M | 0.55 |
| HQY | 104.65 | 9.02B | 1.10B | 105.67M | -197.98M | 0.1475 |
| TEM | 52.48 | 8.56B | 640.44M | -743.28M | -206.93M | 0.00 |
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
GeneDx Holdings Corp. (WGS) Tops Q3 Earnings and Revenue Estimates - MSN
Thompson Davis & CO. Inc. Sells 7,244 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Insider Sell Alert: Katherine Stueland Sells 45,415 Shares of Ge - GuruFocus.com
Katherine Stueland Sells 22,307 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) Stock - MarketBeat
Royce & Associates LP Acquires New Shares in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx CEO Katherine Stueland sells $3.2m in stock - Investing.com
GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover - Yahoo Finance
GeneDx (NASDAQ:WGS) Shares Gap DownHere's What Happened - MarketBeat
GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary - Yahoo Finance
GeneDx Holdings Corp. (NASDAQ:WGSWW) Sees Significant Increase in Short Interest - Defense World
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year - The Motley Fool
Chartwell Investment Partners LLC Purchases New Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Holdings Corp (WGS) Shares Up 5.13% on Nov 12 - GuruFocus.com
Lisanti Capital Growth LLC Makes New Investment in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Achieves Profitability with Strong Q3 Growth - MSN
Brokerages Set GeneDx Holdings Corp. (NASDAQ:WGS) Price Target at $59.33 - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) Q3 2024 Earnings Call Transcript - MSN
Goldman Sachs Group Inc's Strategic Acquisition in GeneDx Holdin - GuruFocus.com
WGSGeneDx Holdings Corp. Latest Stock News & Market Updates - StockTitan
New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields - Yahoo Finance
Zacks.com featured highlights include Snap, GeneDx and Leonardo - Yahoo Finance
Insider Selling: GeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder Sells 865,800 Shares of Stock - MarketBeat
3 Stocks to Buy for Stellar Earnings Acceleration in November - Yahoo Finance
Best Momentum Stocks to Buy for November 4th - Yahoo Finance
GeneDx (NASDAQ:WGS) Posts Earnings Results, Beats Estimates By $0.25 EPS - MarketBeat
GeneDx Holdings Corp (WGS) Shares Gap Down to $77.44 on Nov 1 - GuruFocus.com
US$76.67That's What Analysts Think GeneDx Holdings Corp. (NASDAQ:WGS) Is Worth After These Results - Simply Wall St
GeneDx (NASDAQ:WGS) Shares Gap Down After Insider Selling - MarketBeat
Genedx holdings CFO Kevin Feeley sells shares worth $18,248 By Investing.com - Investing.com Nigeria
Genedx holdings CFO Kevin Feeley sells shares worth $18,248 - Investing.com India
Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds (NTRA) - Seeking Alpha
GeneDx CEO Stueland sells $143,456 in company stock - Investing.com
GeneDx CEO Stueland sells $143,456 in company stock By Investing.com - Investing.com UK
Raymond James & Associates Takes Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Holdings: Phenomenal Gains, More Upside Potential In Medium Term (NASDAQ:WGS) - Seeking Alpha
GeneDx (NASDAQ:WGS) Price Target Raised to $70.00 at The Goldman Sachs Group - MarketBeat
GeneDx Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
GeneDx Holdings Corp (WGS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and First ... By GuruFocus - Investing.com Canada
GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights - BioSpace
GeneDx (NASDAQ:WGS) Sets New 52-Week HighStill a Buy? - MarketBeat
GeneDx Holdings Corp (WGS) Trading 48.22% Higher on Oct 29 - GuruFocus.com
GeneDx stock climbs after Q3 beat (WGS:NASDAQ) - Seeking Alpha
Genetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidance - Yahoo Finance
GeneDx Q3 2024 Earnings Preview - MSN
GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits - Quantisnow
GeneDx (NASDAQ:WGS) Shares Down 3%Here's Why - MarketBeat
Assenagon Asset Management S.A. Has $13.97 Million Stock Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Craig Hallum Raises GeneDx (NASDAQ:WGS) Price Target to $70.00 - Defense World
Craig Hallum Boosts GeneDx (NASDAQ:WGS) Price Target to $70.00 - MarketBeat
GeneDx (WGS) to Release Quarterly Earnings on Tuesday - MarketBeat
Finanzdaten der Genedx Holdings Corp-Aktie (WGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.85%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):